COPD care: different countries, same issues
Chronic Obstructive Pulmonary Disease (COPD) persists as a major global public health issue demanding urgent attention from policymakers. Despite being preventable and treatable, COPD is the third leading cause of death globally* accounting for 3.3 million deaths worldwide. Aquarius Population Health conducted a qualitative research study with 17 clinical experts involved in COPD management from Read More >
Comparing the costs and diagnostic outcomes of using DNA methylation testing instead of liquid-based cytology within HPV primary cervical cancer screening in the Netherlands.
Publication of our research assessing the potential health and economic benefits of improved management of chronic obstructive pulmonary disease in England, Germany, Canada, and Japan.
Publication of our economic evaluation comparing two cervical screening strategies in Belgium: HPV primary versus co-testing
An economic evaluation of two PCR-based respiratory panel assays for patients admitted to hospital with community-acquired pneumonia (CAP) in the UK, France, and Spain
Piss in a pot and pop it in the post: An economic evaluation of vaginal swab and urine self-sampling for HPV primary cervical cancer screening compared with clinician-collected sampling
The cost-effectiveness of Magnetic Resonance-Guided Focused Ultrasound compared to Deep Brain Stimulation for the treatment of essential tremor
Cost-effectiveness of a rapid point-of-care test for diagnosing patients with suspected bloodstream infection in Ireland
Health economic evaluation of an mRNA HR-HPV assay versus a DNA HR-HPV assay for the proposed French cervical screening programme
Identifying the common barriers to optimal COPD care in Japan, Canada, England, and Germany through Evidenced Care Pathways
